Position in DNLI
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,256,698
+$140,186 QoQ
Shares Held
87,741
-20.4% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#91
of 290 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D.A. DAVIDSON & CO. holds $28,520,434 across 19 Biotechnology names. DNLI ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
538,924 | $4,718,279 | |
| 2 | MRNA |
Moderna, Inc.
|
54,290 | $3,801,928 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
100,628 | $3,453,552 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
43,601 | $2,494,849 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,547 | $2,258,631 | |
| 6 | DNLI |
Denali Therapeutics Inc.
This page
|
87,741 | $2,256,698 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
95,540 | $1,616,536 | |
| 8 | ANIX |
Anixa Biosciences Inc
|
539,272 | $1,509,961 |
All Filings in DNLI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,256,698 | 87,741 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,116,512 | 110,235 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,765,463 | 106,933 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||